Blanket Purchase Agreement HT001420A0020
Award Date
1/30/20
Last Date to Order
1/30/25
Federal Agency
Defense Health Agency
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Health Agency (DHA) has awarded a Blanket Purchase Agreement (BPA) to Medi-Physics, Inc., a subsidiary of General Electric Company (GE), to provide radiopharmaceuticals and supplies to military treatment facilities nationwide. The contract has a potential value of $1 million and a period of performance from October 1, 2020 through September 30, 2025. Under this BPA, Medi-Physics will deliver a range of radioactive tracers, medical isotopes, and diagnostic imaging agents used in...
The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sr-Services GMBH on April 1, 2023. The BPA has a potential value of $725,000 and expires on April 23, 2028. It was not subject to any set-aside requirements. The BPA aims to procure radiopharmaceuticals for use in nuclear medical services. Sr-Services GMBH will supply these products to support the Defense Health Agency's mission of providing health care services to U.S. military service members, military families,...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency Contracting Activity (DHACA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to procure various radiopharmaceuticals for use in the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). The single-award, firm-fixed-price BPA is valued at $1,900,000.00 and has a performance period from October 1, 2024 to September 30, 2029. The BPA covers the acquisition of 31 different...
The Defense Health Agency (DHA) has awarded a single-award Blanket Purchase Agreement (BPA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and products. The BPA, established against the Pharmaceuticals and Drugs GSA Schedule, has a ceiling value of $6.5 million and a performance period through July 2028. Under this BPA, Lantheus Medical Imaging will provide diagnostic nuclear imaging supplies and agents to the DHA, including...
The Defense Health Agency awarded a single-award Blanket Purchase Agreement (BPA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, to provide radiopharmaceutical products and services to support diagnostic imaging and treatment procedures at Naval Hospital Pensacola in Florida. The BPA has a potential value of $150,000 and a period of performance from October 11, 2023, to October 10, 2028. Jubilant Radiopharma is...
The provided information describes a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Curium US LLC, a foreign-owned manufacturer of radiopharmaceuticals and nuclear medicine products. The BPA, valued at $8 million, facilitates streamlined procurement of radiopharmaceuticals and related services for DHA and Army Medical Command healthcare facilities. Under this single-award BPA, Curium has received multiple call orders...
The Department of the Army Medical Command awarded a $1 million blanket purchase agreement to Pharmalucence, Inc. to provide various radiopharmaceuticals to military treatment facilities. No set-aside was designated for this single award contract, which has a period of performance from October 1, 2020 through September 30, 2025. Three task orders were subsequently awarded against this blanket purchase agreement by the Defense Health Agency to procure radiopharmaceuticals and related supplies...
The Defense Health Agency (DHA) has awarded a series of Blanket Purchase Agreement (BPA) call contracts to Lantheus Medical Imaging, Inc., a wholly-owned subsidiary of Lantheus Holdings, Inc. These contracts, valued at over $1 million in total ceiling, facilitate the procurement of radiopharmaceuticals, nuclear medicine supplies, and diagnostic imaging agents for military treatment facilities and other federal healthcare providers. Lantheus, a for-profit manufacturer specializing in innovative...
The Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Pharmalucence, Inc. as a single-award contract with a potential value of $1,250,000. The BPA aims to procure radiopharmaceutical supplies for Tripler Army Medical Center in Hawaii over a five-year period of performance from May 2021 through April 2026. Under the BPA, Pharmalucence will provide a range of radiopharmaceutical products to support nuclear medicine diagnostic imaging and related clinical...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Advanced Accelerator Applications USA Inc., a large, foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $23.4 million single-award BPA is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of February 3, 2025. The BPA is for the procurement of LOCAMETZ and NETSPOT, two...